Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.89
+0.11 (0.80%)
Aug 14, 2025, 2:12 PM - Market open
Carlsmed Revenue
Carlsmed had revenue of $10.19M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $32.27M. In the year 2024, Carlsmed had annual revenue of $27.17M with 97.16% growth.
Revenue (ttm)
$32.27M
Revenue Growth
+97.16%
P/S Ratio
9.87
Revenue / Employee
$362,562
Employees
89
Market Cap
368.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCARL News
- 5 hours ago - Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - GlobeNewsWire
- 13 days ago - Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - GlobeNewsWire
- 17 days ago - Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery - GlobeNewsWire
- 21 days ago - Carlsmed: Spine Play Does Not Have My Backing Yet - Seeking Alpha
- 22 days ago - Carlsmed Announces Pricing of Initial Public Offering - Business Wire
- 22 days ago - Carlsmed Announces Launch of Initial Public Offering - Business Wire
- 26 days ago - U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings - Seeking Alpha
- 6 weeks ago - Carlsmed Files For IPO On High Growth And High Operating Losses - Seeking Alpha